8 min read
Monthly FDA Guidance and Regulatory News Review - August 2026
This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...
Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.
Learn More →
Join Veristat at Europe’s largest life sciences partnering conference, BioEurope 2017 in Berlin, Germany.
Veristat works well with growing biotechnology firms, we partner and build long-lasting relationships to help our clients grow their companies and pipelines. Schedule a time to meet with Veristat at BioEurope by completing the form on the right.
A current client started working with Veristat over 6 years ago as a small venture funded company. Our initial engagement began with strategic consulting for their clinical development program, representation at numerous agency meetings (FDA & EMA), and evolved into to running over 15 studies. We helped them as they grew from a 4 person to a 300 person firm and today, we remain a preferred provider. Read the full case study to learn more.
8 min read
Sep 21, 2026 Veristat Blog
This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...
8 min read
Aug 14, 2026 Veristat Blog
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...